Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
13 active Medicare policies list M75.00, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
9 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M75.00 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Chiropractic Services | Mar 23, 2023 | Covered |
| Continuous Passive Motion (CPM) Machines | Mar 15, 2024 | Covered |
| Electrothermal Arthroscopy | Aug 4, 2023 | Covered |
| Manipulation Under General Anesthesia | Mar 29, 2023 | Covered |
| Phonophoresis | Apr 11, 2023 | Covered |
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 30, 2025
| Sep 20, 2023 |
| Covered |
| Policy | Effective | Status of M75.00 |
|---|---|---|
| Therapeutic use of Stem Cells, Blood and Bone Marrow Products | Oct 1, 2026 | Not covered |
| Policy | Effective | Status of M75.00 |
|---|---|---|
| Manipulation Under Anesthesia | Feb 1, 2026 | Covered |